Dr. Ervin Woodle, MD

Claim this profile

University of Cincinnati

Studies Antibody Mediated Rejection
1 reported clinical trial
1 drug studied

Area of expertise

1Antibody Mediated Rejection
Ervin Woodle, MD has run 1 trial for Antibody Mediated Rejection. Some of their research focus areas include:
HLA positive
DSA positive

More about Ervin Woodle, MD

Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Ervin Woodle, MD has experience with
  • Clazakizumab
Breakdown of trials Ervin Woodle, MD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ervin Woodle, MD specialize in?
Ervin Woodle, MD focuses on Antibody Mediated Rejection and other conditions. In particular, much of their work with Antibody Mediated Rejection has involved HLA positive patients, or patients who are DSA positive.
Is Ervin Woodle, MD currently recruiting for clinical trials?
No, Ervin Woodle, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Ervin Woodle, MD has studied deeply?
Yes, Ervin Woodle, MD has studied treatments such as Clazakizumab.
What is the best way to schedule an appointment with Ervin Woodle, MD?
Apply for one of the trials that Ervin Woodle, MD is conducting.
What is the office address of Ervin Woodle, MD?
The office of Ervin Woodle, MD is located at: University of Cincinnati, Cincinnati, Ohio 45267 United States. This is the address for their practice at the University of Cincinnati.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.